|
HLA class I restricted peptides used for IFN-γ ELISpot assays |
|||
| Peptide |
Protein |
Sequence |
HLA-restriction |
|
|
|||
| Gag |
|||
|
|
|||
| g1 |
p17 (71–79) |
GSEELRSLY |
A1 |
| g2 |
p17 (77–85) |
SLYNTVATL |
A*0201 |
| g3 |
p17 (20–28) |
RLRPGGKKK |
A3 |
| g4 |
p24 (217–227) |
ACQGVGGPGHK |
A11 |
| g5 |
p17 (84–92) |
TLYCVHQRI |
A11 |
| g6 |
p17 (28–36) |
KYKLKHIVW |
A24 |
| g7 |
p24 (35–43) |
EVIPMFSAL |
A26 |
| g8 |
p24 (16–23) |
SPRTLNAW |
B7 |
| g9 |
p17 (74–82) |
ELRSLYNTV |
B8 |
| g10 |
p24 (197–205) |
DCKTILKAL |
B8 |
| g11 |
p17 (93–101) |
EIKDTKEAL |
B8 |
| g12 |
p17 (24–31) |
GGKKKKYKL |
B8 |
| g13 |
p24 (131–140) |
KRWIILGLNK |
B27 |
| g14 |
p17 (36–44) |
WASRELERF |
B35A |
| g15 |
p17 (124–132) |
NSSKVSQNY |
B35A |
| g16 |
p24 (122–130) |
PPIPVGDIY |
B35A |
| g17 |
p24 (174–184) |
AEQASQDVKNW |
B44 |
| g18 |
p24 (83–92) |
VHPVHAGPIA |
B55 |
| g19 |
p24 (108–117) |
TSTLQEQIGW |
B57B |
| g20 |
p24 (176–184) |
QASQEVKNW |
B57B |
| g21 |
p24 (15–23) |
ISPRTLNAW |
B57B |
| g22 |
p24 (32–40) |
FSPEVIPMF |
B57B |
| g23 |
p17 (92–101) |
IEIKDTKEAL |
B61 |
|
|
|||
| Pol |
|||
|
|
|||
| p1 |
RT (309–317) |
ILKEPVHGV |
A*0201 |
| p2 |
RT (179–187) |
VIYQYMDDL |
A2 |
| p3 |
RT (485–493) |
ALQDSGLEV |
A2 |
| p4 |
RT (341–350) |
IYQEPFKLNK |
A11 |
| p5 |
RT (158–166) |
AIFQSSMTK |
A11 |
| p6 |
IN (179–188) |
AVFIHNFKRK |
A11 |
| p7 |
RT (448–457) |
RETKLGKAGY |
A29 |
| p8 |
RT (392–401) |
PIQKETWETW |
A32 |
| p9 |
RT (18–26) |
GPKVKQWPL |
B8 |
| p10 |
RT (175–183) |
HPDIVIYQY |
B35A |
| p11 |
RT (156–164) |
SPAIFQSSM |
B35A |
| p12 |
RT (432–441) |
EPIVGAETFY |
B35A |
| p13 |
RT (203–212) |
EELRQHLLRW |
B44 |
| p14 |
RT (397–406) |
TWETWWTEYW |
B44 |
|
|
|||
| Nef |
|||
|
|
|||
| n1 |
nef (180–189) |
VLEWRFDSRL |
A2 |
| n2 |
nef (73–82) |
QVPLRPMTYK |
A11 |
| n3 |
nef (75–82) |
PLRPMTYK |
A11 |
| n4 |
nef (84–92) |
AVDLSHFLK |
A11 |
| n5 |
nef (128–137) |
TPGPGVRYPL |
B7 |
| n6 |
nef (90–97) |
FLKEKGGL |
B8 |
| n7 |
nef (13–20) |
WPTVRERM |
B8 |
| n8 |
nef (135–143) |
YPLTFGWCY |
B18/B49 |
| n10 |
nef (186–193) |
DSRLAFHH |
B35A |
| n11 |
nef (74–84) |
VPLRPMTY |
B35A |
| n12 |
nef (116–125) |
HTQGYFPDWQ |
B57B |
| n13 |
nef (92–100) |
KEKGGLEGL |
B61 |
|
Peptides were identified from the NIH HIV Molecular Immunology Database website [50]. References for each peptide are also available at this website. RT (reverse transcriptase antigen), IN (integrase antigen). AHLA B35 is associated with rapid progression in HIV-1 infection. BHLA B57 is associated with slow/non progression in HIV-1 infection | |||
Hardy et al. Journal of Immune Based Therapies and Vaccines 2007 5:6 doi:10.1186/1476-8518-5-6 |
|||